Loading page…

Riddhi Siddhi Gluco Biols Ltd (RIDDHI) · mywealthgrid

About

Riddhi Siddhi Gluco Biols Ltd is a trading and distribution company in the Industrials sector, operating within commercial services and supplies. With a market cap of ₹525.51 Cr and trading at a PE of 8.55, it is a small-cap business. The company has shown extreme volatility in quarterly revenues (₹4.2 Cr to ₹87.34 Cr) and profitability over recent years.

Face value: ₹10

Market cap

₹505 Cr

P/E

8.2×

P/B

0.3×

Dividend yield

0.4%

ROE

-0.8%

ROCE

2.8%

Debt / equity

0.19

OPM

-5.2%

EPS (TTM)

₹86.2

Book value

₹2,116.7

52-week high

₹825.9

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Revenue is highly unpredictable, ranging from ₹4.2 Cr to ₹87.34 Cr quarterly, suggesting lumpy order flows or accounting inconsistencies that warrant investigation.
Operating margins are unstable (range -23.73% to +51.39%), with current OPM at only 1.47%, leaving little cushion if revenues decline.
Profitability dependent on non-operating items: multiple quarters show negative operating margins yet positive net profits, indicating reliance on gains or one-time items rather than core trading operations.
Return on equity of 3.98% is very low, indicating shareholder capital is not being deployed efficiently to generate returns.

Generated analysis · source review pending

Growth drivers

Operating margin of 1.47% vs. historical high of 51.39% (Jun 2019) and mid-range of 13.63% (Sep 2019): if management can stabilize and recover margins toward prior levels, profit would expand substantially on current or growing revenue without requiring large volume increases.
Highest quarterly revenue of ₹87.34 Cr (Sep 2020) vs. recent lows: researcher should verify whether historical high-revenue quarters are sustainable, driven by one-time orders, or depend on pricing that may not persist.
Recent 1-year stock return of 37.34% suggests market re-rating: verify whether this reflects genuine operational improvement in margins or profitability, or simply valuation expansion of a low-PE (8.55) stock.

Generated analysis · source review pending

₹710.9+26.7%1Y

Beta

0.99

Moves with the index

Volatility (1y)

50.4%

Annualised, daily returns

RSI (14)

37.4

Neither overbought nor oversold

Rel. strength (1y)

15.8%

Ahead of the market

Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.

Quick read

rule-based

Pros

+High promoter holding of 75% with no pledge

Cons

−Low return on equity of 2.3% (3-yr avg)
−Revenue shrank over the last 5 years (-13.9% a year)
−Low dividend payout of 3.5% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

56/100

Business quality: 21
Growth: 44
Valuation: 100

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Redington LimitedREDINGTONREDINGTON	₹31,112 Cr	₹33,749 Cr	₹1,28,133 Cr	₹2,537 Cr	1.9%	₹1,701 Cr	1.1%	21.7%	15.8%	34
Mmtc LimitedMMTCMMTC	₹8,444 Cr	₹8,444 Cr	₹3 Cr	₹-179 Cr	—	₹447 Cr	—	-0.5%	20.3%	-2,38,864
Mstc LimitedMSTCLTDMSTCLTD	₹4,969 Cr	₹5,114 Cr	₹386 Cr	₹236 Cr	60.6%	₹234 Cr	59.1%	34.9%	26.6%	-92
Bn Agrochem LimitedBNAGROCHEMBNAGROCHEM	₹2,228 Cr	₹2,310 Cr	₹299 Cr	₹-37 Cr	-12.5%	₹20 Cr	6.6%	12%	8.5%	130
Creative Newtech LimitedCNLCNL	₹1,619 Cr	₹1,943 Cr	₹2,783 Cr	₹99 Cr	3.2%	₹74 Cr	2.6%	29.2%	21.4%	75
Pervasive Commodities LtdPERVASIVEPERVASIVE	₹1,090 Cr	₹1,090 Cr	₹43 Cr	₹-0 Cr	-1.1%	₹-0 Cr	-0.1%	0%	-0.1%	548
RRP Defense LtdRRPDEFENSERRPDEFENSE	₹842 Cr	₹844 Cr	₹12 Cr	₹-1 Cr	-8.4%	₹-1 Cr	-8.2%	-13.7%	-13.7%	-15
The Yamuna Syndicate LtdYSLYSL	₹779 Cr	₹779 Cr	₹69 Cr	₹2 Cr	2.2%	₹52 Cr	75.3%	0.3%	4%	60
The State Trading Corporation Of India LimitedSTCINDIASTCINDIA	₹636 Cr	₹1,811 Cr	₹0 Cr	₹-46 Cr	—	₹21 Cr	—	—	—	—
SMT Engineering LtdSMTELSMTEL	₹598 Cr	₹679 Cr	₹162 Cr	₹41 Cr	25%	₹23 Cr	14.2%	33.2%	25.2%	395
Bijoy Hans LtdARVAYAARVAYA	₹576 Cr	₹579 Cr	₹0 Cr	₹-1 Cr	—	₹0 Cr	—	-3.9%	-3.9%	—
Riddhi Siddhi Gluco Biols LtdRIDDHIRIDDHI	₹505 Cr	₹787 Cr	₹236 Cr	₹-12 Cr	-5.2%	₹61 Cr	-5.2%	2.8%	-0.8%	65

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	343	510	805	682	498	521	173	268	136	236
COGS	220	349	632	482	392	369	141	226	98	206
Gross profit	123	161	173	199	105	152	32	42	38	30
	136	208	183	122	119	142	32	39	36	42
	-13	-47	-10	77	-14	10	1	3	2	-12
OPM %	-3.9%	-9.2%	-1.3%	11.3%	-2.7%	2%	0.4%	1.3%	1.5%	-5.2%
Depreciation	28	35	34	35	37	37	12	11	9	8
Interest	33	50	62	40	26	20	8	9	10	18
	134	111	76	70	59	64	67	81	88	36
Profit before tax	59	-21	—	—	-18	18	-70	51	-4	-2
Tax	15	25	-39	6	44	16	15	8	8	10
Tax %	25.7%	120.2%	—	—	241.7%	87.5%	21.5%	14.6%	225.4%	488%
	44	-45	9	67	-62	2	-85	44	-12	-12
PAT margin %	12.8%	-8.9%	1.1%	9.9%	-12.4%	0.4%	-49.1%	16.4%	-9%	-5.2%
EPS (₹)	56.3	-60	26.6	68.4	-65.6	20.1	-119.1	61.5	-17.1	-17.2
EPS adjusted (₹)	61.6	-63.6	12.4	94.3	-65.6	20.1	46.1	79.5	86.2	-17.2
	0%	—	0%	2.9%	—	5%	—	4.9%	—	—
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	7	7	7	7	7	7	7	7	7	7	7
Reserves	1,360	1,316	1,382	1,429	1,417	1,446	1,497	1,425	1,530	1,542	1,502
Minority interest	107	178	168	165	133	99	87	58	55	38	30
	419	644	440	317	231	209	140	80	70	99	282
	183	228	146	161	202	179	106	122	112	99	70
Total equity & liabilities	2,075	2,373	2,143	2,078	1,991	1,941	1,838	1,692	1,774	1,784	1,891
	783	769	744	723	746	769	737	392	381	433	426
CWIP	1	2	16	57	66	0	0	0	—	—	0
Investments	917	969	470	352	158	175	198	209	339	307	606
	374	633	912	946	1,021	996	902	1,091	1,054	1,045	860
Total assets	2,075	2,373	2,143	2,078	1,991	1,941	1,838	1,692	1,774	1,784	1,891

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2018	Mar 2019	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	21.4%	29.2%	21.2%	29.2%	18.7%	15.7%	27.8%	12.7%
EBITDA margin %	-1.3%	11.3%	-2.7%	2%	0.4%	1.3%	1.5%	-5.2%
EBIT margin %	-5.6%	6.2%	-10.3%	-5.1%	-6.4%	-2.8%	-4.8%	-8.7%
PAT margin %	1.1%	9.9%	-12.4%	0.4%	-49.1%	16.4%	-9%	-5.2%
Working capital
Receivable days	23	26	75	35	91	31	33	13
Inventory days	213	335	203	56	12	8	166	78
Payable days	—	59	75	53	25	12	28	25
NWC days	—	303	203	37	77	27	171	65
Leverage
Current ratio	2.57	2.62	2.05	3.46	5.12	4.94	3.89	4.07
Debt to EBITDA	—	4.12	—	13.51	115.77	20.62	49.8	—
Debt to equity	0.32	0.22	0.14	0.09	0.06	0.05	0.06	0.19
Interest coverage	0.5	2.8	0.3	1.9	7.4	8.3	8.3	2.7
Asset turnover	0.38	0.33	0.26	0.28	0.1	0.15	0.08	0.12
Return ratios
Return on assets %	0.4%	3.2%	-3.2%	0.1%	-5%	2.5%	-0.7%	-0.6%
Return on capital employed %	1.8%	6.5%	0.5%	2.3%	3.4%	4.5%	4.9%	2.8%
Return on equity %	0.6%	4.7%	-4.3%	0.1%	-5.9%	2.9%	-0.8%	-0.8%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.54%	74.54%	74.54%	74.54%	74.54%	74.54%	74.54%	74.54%	74.54%	74.54%	86.55%	75%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	2.67%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	25.45%	25.45%	25.45%	25.45%	25.45%	25.45%	25.45%	25.45%	25.45%	25.45%	13.44%	22.32%
No. of shareholders	—	—	—	—	—	—	—	—	4,216	4,232	4,171	3,996

Promoter holding up 0.46 percentage points since Sep 2023.

Mr. GANPATRAJ CHOWDHARYExecutive Director-Chairperson-MD
Mr. SIDDHARTH CHOWDHARYExecutive Director
Mukeshkumar SamdariaChief Finance Officer
Mr. BALVEERMAL SINGHVINon-Executive - Independent Director
Mrs. SANGITA SHINGINon-Executive - Independent Director
Mr. MAHENDRA KUMAR BHANDARINon-Executive - Independent Director
Sharad JainCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Riddhi Siddhi Gluco Biols Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Credit ratings

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

15

Final dividend18 Sept 2026 · ex-date₹3
Final dividend18 Sept 2025 · ex-date₹3
Final dividend17 Sept 2024 · ex-date₹3
Final dividend18 Sept 2023 · ex-date₹1.5
Final dividend15 Sept 2022 · ex-date₹1
Dividend dividend5 Sept 2019 · ex-date₹2
Dividend dividend18 Sept 2015 · ex-date₹3
Dividend dividend7 Aug 2014 · ex-date₹3
Dividend dividend12 Sept 2013 · ex-date₹10
Dividend dividend21 Nov 2012 · ex-date₹25
Dividend dividend19 Sept 2011 · ex-date₹12.5
Dividend dividend11 Aug 2010 · ex-date₹5
Dividend dividend17 Sept 2009 · ex-date₹2
Dividend dividend23 Sept 2008 · ex-date₹3
Dividend dividend13 Sept 2007 · ex-date₹3

1

Board meeting to consider results13 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

30 announcementsExport CSV

18 May 2026, 7:34 pmCompany Update

Board Meeting Intimation for Approval And Adoption Of Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March, 2026.

Board Meeting Rescheduled PDF

14 May 2026, 10:53 amBoard Meeting

Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors Of Riddhi Siddhi Gluco Biols Limited Scheduled To Be Held On 19.05.2026.

Exchange filing PDF

30 Apr 2026, 6:50 pmOthers

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A PDF

27 Apr 2026, 5:57 pmCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

27 Apr 2026, 5:43 pmCompany Update

Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Completion Of Acquisition Of Identified Assets From Cargill India Private Limited.

General PDF

8 Apr 2026, 8:00 pmCompany Update

Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015- Intimation Of Proposal Received From Mr Ganpatraj Chowdhary, Promoter Of Company For His Intention To Offer For Sale ("OFS") Of 8,23,422 Equity Shares In Order To Comply With MPS.

General PDF

Date	Category	Subject	Filing
18 May 2026, 7:34 pm	Company Update Board Meeting Rescheduled	Board Meeting Intimation for Approval And Adoption Of Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March, 2026.	PDF
14 May 2026, 10:53 am	Board Meeting	Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors Of Riddhi Siddhi Gluco Biols Limited Scheduled To Be Held On 19.05.2026.

Loading announcements…

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0	-284	-34	-1	116	130	161	1	9	-28	-9
	-67	65	269	163	30	-91	-71	8	21	21	-22
	-55	192	-263	-169	-131	-68	-93	2	-41	8	140
Net cash flow	-122	-27	-28	-7	15	-29	-2	11	-11	-0	108
Free cash flow	—	—	—	—	—	130	155	0	-4	-77	-10
CFO / Operating profit %	—	—	—	-1.7%	—	—	—	78.3%	263.6%	—	—

Riddhi Siddhi Gluco Biols Ltd

Riddhi Siddhi Gluco Biols Ltd

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Credit ratings

Events

15

1

Announcements

15

1

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Credit ratings

Compounded sales growth

Stock price CAGR

Return on equity

Riddhi Siddhi Gluco Biols Ltd

Riddhi Siddhi Gluco Biols Ltd

About

Key insights

Key risks

Growth drivers

Risk & technicals

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Credit ratings

Events

Dividends15

Board meetings1

Announcements

Dividends15

Board meetings1

Ratio timeline

Quarterly record

Board and management

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Credit ratings

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Stock price CAGR

Return on equity

15

1

15

1